Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/606609]Researchers: Dr Richard Burke (Principal investigator)
Brief description Platinum-based anti cancer drugs such as Cisplatin are effective against a number of cancers of the head, colon, lungs and ovaries. Tumour resistance to these drugs has been closely associated with changes in genes that control the movement of copper in and out of cells. We hypothesize that the same genes regulate distribution of both copper and Cisplatin. By investigating these pathways, we aim to find ways to predict and prevent tumour resistance to this important anti cancer treatment.
Funding Amount $AUD 268,328.69
Funding Scheme NHMRC Project Grants
Notes Standard Project Grant
- nhmrc : 606609
- PURL : https://purl.org/au-research/grants/nhmrc/606609
